Another nail in the coffin for #naltrexone. #opioidusedisorder https://t.co/Ft9JdSUyAt
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Newly released today: Management of opioid use disorders: a national clinical practice guideline from @CrismCan via @CMAJ: https://t.co/JoeoGat98G #opioidcrisis #opioids #addiction
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the risk of toxicity, morbidity and death, and to facilitate safer take-home dosing." Recommendation: STRONG Evidence quality: HIGH https://t.
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Management of opioid use disorders: a national clinical practice guideline KEY POINTS Opioid use disorder is... https://t.co/RyoSdEoJpp
This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access in @CMAJ https://t.co/I0Unjj9uoG
Management of opioid use disorders: a national clinical practice guideline By @CMAJ MARCH 5, 2018 https://t.co/aXaXf5LCJR 👁️👍@canadanurses @RNAO @DorisGrinspun @CANdrugpolicy @CFNU @CRNBC @ontarionurses #Canada 🇨🇦 https://t.co/1eL7bpbT2E
New practice guideline! By @CMAJ - Management of opioid use disorders: a national clinical practice guideline #cdnhealth #MedEd https://t.co/7pVEonzNEL
RT @FarmaciaOesteAP: (CMAJ) GPC sobre manejo del abuso de opioides https://t.co/To8Pb622RS
RT @FarmaciaOesteAP: (CMAJ) GPC sobre manejo del abuso de opioides https://t.co/To8Pb622RS
(CMAJ) GPC sobre manejo del abuso de opioides https://t.co/To8Pb622RS